Insecticide-treated baby wraps to prevent malaria
Part of Infections clinical trials.
This study tests whether baby wraps treated with insecticide can help prevent malaria in infants. If you join, your baby would use these wraps, and researchers will see if they lower the risk of malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need a working phone and be able to travel to a study site for visits.
- Your baby must be between 2 and 4 months old and be a single birth (not twins or more).
- You and your baby must come for the 10-week immunization visit at a study site.
- Your baby cannot be HIV-positive or have sickle cell disease, and you cannot be allergic to the insecticides used in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.
This study tests if giving schoolchildren malaria-prevention medicine at certain times can lower malaria in the community. It might help protect your child and others from getting sick.
This trial tests a long-acting mosquito repellent that could help prevent malaria. It is for children living in the study area, and simply involves letting us know if your child is home for a visit.
This study tests a new way to prevent malaria in children living in Busia District, Uganda. It combines malaria vaccines with preventive medicine to see if it offers better protection than current methods.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.